Skip to main content
PMC home page
Heart logoLink to Heart
. 1999 Mar;81(3):248–251. doi: 10.1136/hrt.81.3.248

Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study

D Strachan 1, D Carrington 1, M Mendall 1, B Butland 1, P Sweetnam 1, P Elwood 1
PMCID: PMC1728973  PMID: 10026345

Abstract

OBJECTIVE—To assess the role of cytomegalovirus (CMV) infection in primary ischaemic heart disease.
METHODS—Plasma specimens collected during 1979-83 from men in Caerphilly, south Wales, were analysed for IgG antibodies to CMV by enzyme linked immunosorbent assay and latex tests. Incident ischaemic heart disease events were ascertained after five and 10 years from death certificates, hospital records, and ECG changes; 195 incident ischaemic heart disease cases were compared with 216 controls of a similar age drawn from the rest of the cohort.
RESULTS—164 cases (84%) and 180 controls (83%) were seropositive for CMV. Optical density, an indicator of CMV antibody titre, was similar for cases and controls. Among controls, seropositivity was not associated with age, socioeconomic status currently or in childhood, smoking, height, body mass index, blood pressure, total cholesterol, fibrinogen, plasma viscosity, or leucocyte count. The unadjusted odds ratio relating CMV seropositivity to incident ischaemic heart disease was 1.06 (95% confidence interval 0.63 to 1.79) and was little changed (1.11, 0.63 to 1.97) after adjustment for age, smoking, body mass index, systolic blood pressure, total cholesterol, and socioeconomic status currently and in childhood.
CONCLUSIONS—CMV infection is unlikely to be a strong risk factor for development of myocardial infarction in middle aged men.


 Keywords: cytomegalovirus; coronary artery disease; atherosclerosis

Full Text

The Full Text of this article is available as a PDF (115.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam E., Melnick J. L., Probtsfield J. L., Petrie B. L., Burek J., Bailey K. R., McCollum C. H., DeBakey M. E. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 1987 Aug 8;2(8554):291–293. doi: 10.1016/s0140-6736(87)90888-9. [DOI] [PubMed] [Google Scholar]
  2. Bainton D., Miller N. E., Bolton C. H., Yarnell J. W., Sweetnam P. M., Baker I. A., Lewis B., Elwood P. C. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J. 1992 Jul;68(1):60–66. doi: 10.1136/hrt.68.7.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Booth J. C., Hannington G., Aziz T. A., Stern H. Comparison of enzyme-linked immunosorbent assay (ELISA) technique and complement-fixation test for estimation of cytomegalovirus IgG antibody. J Clin Pathol. 1979 Feb;32(2):122–127. doi: 10.1136/jcp.32.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Booth J. C., Hannington G., Bakir T. M., Stern H., Kangro H., Griffiths P. D., Heath R. B. Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody. J Clin Pathol. 1982 Dec;35(12):1345–1348. doi: 10.1136/jcp.35.12.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cour M. I., López de Atalaya F. J., Palau L., Fernández Contreras E., Perezagua C. Lack of serological association between herpesvirus and atherosclerosis. Lancet. 1989 Feb 4;1(8632):279–279. doi: 10.1016/s0140-6736(89)91291-9. [DOI] [PubMed] [Google Scholar]
  6. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997 Aug 9;350(9075):430–436. doi: 10.1016/S0140-6736(97)03079-1. [DOI] [PubMed] [Google Scholar]
  7. Dummer S., Lee A., Breinig M. K., Kormos R., Ho M., Griffith B. Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J Med Virol. 1994 Nov;44(3):305–309. doi: 10.1002/jmv.1890440316. [DOI] [PubMed] [Google Scholar]
  8. Griffiths P. D. Chronic cytomegalovirus infection. J Virol Methods. 1988 Sep;21(1-4):79–86. doi: 10.1016/0166-0934(88)90054-7. [DOI] [PubMed] [Google Scholar]
  9. Gulizia J. M., Kandolf R., Kendall T. J., Thieszen S. L., Wilson J. E., Radio S. J., Costanzo M. R., Winters G. L., Miller L. L., McManus B. M. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol. 1995 Aug;147(2):461–475. [PMC free article] [PubMed] [Google Scholar]
  10. Hendrix M. G., Daemen M., Bruggeman C. A. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol. 1991 Mar;138(3):563–567. [PMC free article] [PubMed] [Google Scholar]
  11. Hendrix M. G., Salimans M. M., van Boven C. P., Bruggeman C. A. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol. 1990 Jan;136(1):23–28. [PMC free article] [PubMed] [Google Scholar]
  12. Krech U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Organ. 1973;49(1):103–106. [PMC free article] [PubMed] [Google Scholar]
  13. Melnick J. L., Hu C., Burek J., Adam E., DeBakey M. E. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol. 1994 Feb;42(2):170–174. doi: 10.1002/jmv.1890420213. [DOI] [PubMed] [Google Scholar]
  14. Melnick J. L., Petrie B. L., Dreesman G. R., Burek J., McCollum C. H., DeBakey M. E. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 1983 Sep 17;2(8351):644–647. doi: 10.1016/s0140-6736(83)92529-1. [DOI] [PubMed] [Google Scholar]
  15. Nieto F. J., Adam E., Sorlie P., Farzadegan H., Melnick J. L., Comstock G. W., Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 1996 Sep 1;94(5):922–927. doi: 10.1161/01.cir.94.5.922. [DOI] [PubMed] [Google Scholar]
  16. Ossewaarde J. M., Feskens E. J., De Vries A., Vallinga C. E., Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect. 1998 Feb;120(1):93–99. doi: 10.1017/s0950268897008303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sorlie P. D., Adam E., Melnick S. L., Folsom A., Skelton T., Chambless L. E., Barnes R., Melnick J. L. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol. 1994 Jan;42(1):33–37. doi: 10.1002/jmv.1890420107. [DOI] [PubMed] [Google Scholar]
  18. Speir E., Modali R., Huang E. S., Leon M. B., Shawl F., Finkel T., Epstein S. E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994 Jul 15;265(5170):391–394. doi: 10.1126/science.8023160. [DOI] [PubMed] [Google Scholar]
  19. Yarnell J. W., Baker I. A., Sweetnam P. M., Bainton D., O'Brien J. R., Whitehead P. J., Elwood P. C. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991 Mar;83(3):836–844. doi: 10.1161/01.cir.83.3.836. [DOI] [PubMed] [Google Scholar]
  20. Yarnell J. W., Milbank J. E., Munro J. A., Howells C. H. The prevalence of cytomegalovirus antibody in women: an epidemiological study from South Wales. Public Health. 1982 Sep;96(5):251–255. doi: 10.1016/s0033-3506(82)80047-4. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES